JPM
JPMorgan Chase & Co.
stock NYSE

No, they have very little in common aside from JPM. Q is based on QQQ holdings, very concentrated, and much more volatile, hence the higher distribution. I is a lot more defensive in nature and not nearly as volatile. They're both decent funds with good management. How much you should allocate to each depends on how risk averse you are.

JPM healthcare is the ultimate casino for the small ones. 

sounds like China is giving JPM enough rope to hang themselves

WVE could be interesting. CEO presenting at JPM healthcare next week.

JPM will be huge

Waiting for JPM updates. Sluggish movement so far though

EASY BANKS & BIOTECH the M&A floodgates are wide open JPM health next week the super bowl of biotech M&A Bank earnings also next week heavy beats expected. Experts say 40% of small banks & 30 % of small bio will be bought out & its already started. Dont be fool & listen to some here saying chase Rare earths or Nuke or some other spec sector & if your under 40 you dont need Div stock. best way to take advantage is buy XBI & KBE

Yeah, when JPM dropped to 300 a few weeks back that was a fucking Christmas gift with an extra large red bow on it. Should have gone in hard with shares or calls

lol JPM taking over apple card, jesus christ. I've got my mortgage through JPM, my main bank account is in JPM and now my apple card is through JPM.
so basically calls on JPM

The more interesting question isn't whether JPM can manipulate from Shanghai - it's why they need a presence there at all.
If the paper market in New York actually controlled price discovery globally, you wouldn't see a persistent $6-10 premium in Shanghai. Arbitrage would close that gap in hours.
But it doesn't close. Because arbitrage requires moving physical metal - and metal that goes into China doesn't come back out easily.
JPM in Shanghai isn't about manipulation. It's about access. When your Western clients start asking for physical delivery and your COMEX-registered inventory is draining, you need to source metal from somewhere.
Whether China lets them actually move it is another question entirely.

GENERAL NEWS:
* INITIAL JOBLESS CLAIMS 208K VS 212K EXPECTED

MAG7 NEWS:
* NVDA tightened Rubin HBM4 specs in 3Q25, lifting per pin speed to 11+ Gbps, forcing SK hynix, Samsung, and Micron to redesign & resubmit samples.
* NVDA - China is preparing to approve some H200 imports as soon as this quarter for select commercial use, while barring military, sensitive govt, critical infrastructure and SOEs.
OTHER COMPANIES:
* Defence names all ripping on the following comments from Trump yesterday: OUR MILITARY BUDGET FOR THE YEAR 2027 SHOULD NOT BE $1 TRILLION DOLLARS, BUT RATHER $1.5 TRILLION DOLLARS
* BE - shares are ripping after an AEP filing said an unregulated sub signed a $2.65B purchase for solid oxide fuel cells plus a 20-year offtake with a high grade customer for 100% of output from a Wyoming (Cheyenne area) fuel cell plant.
* ACHR - says its building its next aviation AI stack on NVIDIA’s IGX Thor, with plans to integrate the safety-capable module into future versions of its aircraft programs.
* PGR - Barclays upgrades to overweight from equal weight, PT to 265 from 257. "Personal Lines: Turning to personal lines underwriting, while our view was relatively unfavorable in 2025, we see improvement relative to commercial underwriters this year. Competitive market headwinds are now better understood, growth expectations more accurately reflect pricing dynamics, and valuations have adjusted in anticipation of competition. As a result, we adopt a more neutral industry outlook and upgrade Progressive (PGR) to Overweight. We believe PGR’s recent rate decreases could support stronger-than-expected growth in 2026, and we project above-consensus policy-in-force growth for the company."
* ATAI - Set 2026 milestones ahead of JPM. BPL-003 TRD Phase 3 guidance in Q1’26 and planned Phase 3 start in Q2’26 after FDA End-of-Phase 2. VLS-01 (DMT buccal film) Phase 2 topline due H2’26. EMP-01 (oral R-MDMA) Phase 2a topline due Q1’26. Runway expected into 2029
* NKE - Needham downgrades to hold from Buy, lthough we continue to believe that CEO Elliott Hill is doing the right things for the brand long-term (re-focus on sport, re-focus on product innovation, re-engagement with key wholesale partners, etc.), we believe that the turnaround is taking longer than expected, and visibility into the turnaround remains low.
* UPS - Wolfe Research downgrades to peer perform from outperform. Looking ahead, we expect 1H’26 earnings to remain under pressure as UPS continues to pare Amazon volumes with cost-outs lagging. UPS also faces year-over-year headwinds in International Package until lapping the end of de minimis out of China in May. So, we see risk that CY26 EPS is flat to down year-over-year, with our CY26 estimate now 9% below consensus. With valuation now back towards historical averages on our below-consensus estimates, we’re lowering our rating from Outperform to Peerperform."
* FIG - Wells Fargo upgrades to overweight from equal weight, PT 52. "Our Call: FIG shares have fallen more than 70% from (admittedly rich) prior post-IPO peaks (vs. NASDAQ +14%) as investors continue to evaluate where the company fits in the broader GenAI vs. application software discussion. We see the company deserving of a premium given its de facto status within product design, track record of delivering efficient growth, innovative product set capable of driving continued customer expansion, and increasing signs of evidence in FIG’s ability to deliver tangible GenAI-enabled value in ’26 via Make.
* ROKU - evercore upgrades to outperform from in line, raises PT to 145 from 105. We are upgrading ROKU from In Line to Outperform, raising estimates, and raising our price target from $105 to $145 (31% upside vs. current levels), based on 25x 2027 EV/EBITDA. We think ROKU faces a number of company-specific catalysts in ’26, including Amazon DSP integration, growth of Roku Ad Manager, new premium subscription channels within The Roku Channel experience, and a home screen refresh, and should also be well positioned to benefit from significant ’26 industry catalysts including the ’26 World Cup (hosted across North America, with more teams and more games vs. ’22), the ’26 Winter Olympics, and the U.S. mid-term political cycle.
* GAP - UBS upgrades to buy from neutral, pt 41. "We believe GAP's sales and EPS growth rates will inflect positively over the NTM for two reasons: (1) GAP's initiatives to grow its beauty and handbag businesses will start to benefit sales and earnings, and (2) Athleta's sales growth rate will improve. We forecast 4.4% FY26E revenue growth vs. 1.9% in FY25E. We also model 14% FY26E EPS growth vs. -2% in FY25E. This scenario will send Street EPS estimates higher, in our view. Our FY26 and FY27 EPS estimates are 7% and 13% above consensus. We also believe a sales growth rate inflection will boost the stock's P/E ratio to 14x from 11x today."
* TOST \_ Wolfe downgrades to peerperfrm from outperform. We see the company entering 2026 with healthy momentum, driven by continued penetration of the core and increasing contributions from the new TAMs. That said, competition in the restaurant POS space continues to increase as peers invest in tech and GTM. TOST is actively investing to solidify its market leadership, likely leading to less margin expansion in 2026 (though this could translate to improved top-line growth) than prior years.
* SHEl - says Q4 oil and gas production should tick up to 1.84–1.94m boe/d (vs 1.83m in Q3), but it warned oil trading will be “significantly lower” than last quarter, pressuring earnings.
* CVX - U.S. Gov negotiating to expand Venezuela oil license. U.S. also wants other U.S. companies to be involved in oil exports from the country - Reuters
* RTX - TRUMP" MUST STEP UP, START INVESTING IN INVESTMENT LIKE PLANTS AND EQUIPMENT, OR THEY WILL NO LONGER BE DOING BUSINESS WITH THE DEPT OF WAR
* ARM - REORGANIZES COMPANY, LAUNCHES PHYSICAL AI UNIT TO EXPAND ROBOTICS CHIP TECH EFFORT, EXECUTIVES SAY - RTRS
* APLD up on earnings.
OTHER NEWS:
* WSJ: China has reportedly halted reviews for rare earth export licenses to Japan after recent remarks tied to Taiwan. Exporters say heavy rare earths and magnet shipments are being restricted across industries, not just defense.
* US ENERGY SECRETARY CHRIS WRIGHT:
* INTEREST IN VENEZUELAN INVESTMENT IS 'TREMENDOUS'
* EASY OPPORTUNITY TO GROW CHEVRON PRODUCTION IN VENZ.

VOO is not the etf with least volatility.
that would be something like Money Market ETFs.
No one can give you advice. It all depends on what you want...Monthly dividends? JPM equity Premium ETFs. Capital preservation? UBS equity defensiv put ETF, geo diversification? All world ETFa.
The US market is pretty expensive right now, EU and Chinese equities are cheap.
Tech equities have valuation concerns.
pharma stocks mostly depend on weight loss pills these days
If you think an S&P 500 ETF is too tech concentrated, you can buy an equal weight S&P 500 etf.
tldr: you have to know what you want and the current state of the market even with ETFs there's a lot of risk especially with orange man waking up and deciding to do his next mind-blowing thing

JPM move to the Shanghai exchange in Nov.

JPM will outperform the market.

These are my own high-conviction picks. I'm a pretty risk-friendly guy with not a lot of capital, so keep that in mind:
1. $GOOG
imo the best positioned Mag7 at the moment with their developments in AI, cloud, robotics
2. $SMH
overall exposure to all the biggest semiconductor/chip manufacturers (SMH has the best portfolio imo)
3. $BRK-B
I don't hold this because I don't want any defensive stocks but i think it is an excellent buy to hold forever
4. $PANW
Cybersecurity pick that has been described by many as 'best-in-class' - also cybersecurity will only keep growing in the future as more stuff gets digitalized (also pretty cheap right now)
5. $ABBV
biotech/pharma company with great track record (i personally know a couple of very smart people that work here)
then some more speculative plays (admittedly these make up a bigger part of my portfolio)
1. $QXO
uncle brad
2. $TE
Interesting solar energy play (although I'm a bit skeptical on solar)
3. $NBIS/$IREN
There's a bunch of names in the AI/cloud/DC infrastructure space popping up right now, these are my two highest conviction choices
4. $SMR/$OKLO
Haven't bought these yet - still deciding which one I like better
5. $SOFI
6. $RKLB/$ASTS
I like these but have sold out recently waiting for a dip, will continue monitoring
more defensive picks like $KO, $PG, $WM and financial stocks like $JPM are also interesting choices

Didn’t JPM launch on Base already?

Uh, nobody is doing that. The current Apple Card uses MasterCard as the processor. The switch to JPM will likely mean switching to Visa since that's what all existing Chase cards use.

Not financial advice, but as a starting point I would personally look at my 401k as more core index diversified investments. seems like at 26 this will be the bulk of my foundation / base. $10k now and I assume over years new money will be added over time. assuming brokerage is like \~20% of your portfolio, i personally would be ok taking additional risk via individual stocks. Would probably just buy like 4-5 big company stocks i liked and just hold. I would probably mix it up with WMT, GOOGL, NVDA, JPM, etc. Assuming i'm a big believer in this AI movement, maybe i'll add a higher volatility stock like CRWV or something. (stocks are just for example purposes).

JPM has largest share according to this source:
https://www.cardrates.com/advice/credit-card-issuer-market-share/

I just dropped $2k or so into the market about $525 adding weight to my international ETFs.
$625 on opening a VICI position, added $280 to my PayPal position, $100 to my UBER position, $85 to my BYDDY position, $100 to my JPM position, Also put another $100 into catching the Versant falling knife.